Polaryx Therapeutics, Inc. (PLYX): Form 8-K filed 2026-07-17
- Accepted by EDGAR
- 2026-07-17 08:00 ET
- Event date
- 2026-07-16
- Accession no.
- 0001213900-26-078912
- Original filing
- SEC EDGAR filing index
Items reported
- Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
The company discloses the date by which shareholders must submit director nominees for inclusion in its proxy materials, when that date was not previously disclosed. - Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | CURRENT REPORT | ea0298274-8k_polaryx.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.